检索结果 - Daniel Checketts

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
    Efficacy and safety of nabiximols cannabinoid medicine for paediatric spasticity in cerebral palsy or traumatic brain injury: a randomized controlled trial

    Efficacy and safety of nabiximols cannabinoid medicine for paediatric spasticity in cerebral palsy or traumatic brain injury: a randomized controlled trial 由 Charlie Fairhurst, Ram Kumar, Daniel Checketts, Bola Tayo, Susie Turner

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Cannabidiol efficacy independent of clobazam: Meta‐analysis of four randomized controlled trials

    Cannabidiol efficacy independent of clobazam: Meta‐analysis of four randomized controlled trials 由 Orrin Devinsky, Elizabeth A. Thiele, Stephen Wright, Daniel Checketts, Gilmour Morrison, Eduardo Dunayevich, Volker Knappertz

    出版 2020
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials

    Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials 由 Boudewijn Gunning, Maria Mazurkiewicz‐Bełdzińska, Richard Chin, Hari Bhathal, Charlotte Nortvedt, Eduardo Dunayevich, Daniel Checketts

    出版 2020
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  4. 4
    A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma

    A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma 由 Chris Twelves, Michael Sabel, Daniel Checketts, Sharon A. Miller, Bola Tayo, Maria Jové, Lucy Brazil, Susan Short

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Cannabidiol in patients with Lennox‐Gastaut syndrome: Interim analysis of an open‐label extension study

    Cannabidiol in patients with Lennox‐Gastaut syndrome: Interim analysis of an open‐label extension study 由 Elizabeth A. Thiele, Eric D. Marsh, Maria Mazurkiewicz‐Bełdzińska, Jonathan J. Halford, Boudewijn Gunning, Orrin Devinsky, Daniel Checketts, Claire Roberts

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome

    Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome 由 Ian Miller, Ingrid E. Scheffer, Boudewijn Gunning, Rocío Sánchez‐Carpintero, António Gil‐Nagel, Μ. Scott Perry, Russell P. Saneto, Daniel Checketts, Eduardo Dunayevich, Volker Knappertz

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Long‐term efficacy and safety of cannabidiol in patients with treatment‐resistant epilepsies: Four‐year results from the expanded access program

    Long‐term efficacy and safety of cannabidiol in patients with treatment‐resistant epilepsies: Four‐year results from the expanded access program 由 Jerzy P. Szaflarski, Orrin Devinsky, Merrick Lopez, Yong D. Park, Pilar Pichon Zentil, Anup D. Patel, Elizabeth A. Thiele, Robert Wechsler, Daniel Checketts, Farhad Sahebkar

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome

    Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome 由 Orrin Devinsky, Anup D. Patel, J. Helen Cross, Vicente Villanueva, Elaine Wirrell, Michael Privitera, Sam M. Greenwood, Claire Roberts, Daniel Checketts, Kevan VanLandingham, Sameer M. Zuberi

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Time to onset of cannabidiol (CBD) treatment effect in Lennox–Gastaut syndrome: Analysis from two randomized controlled trials

    Time to onset of cannabidiol (CBD) treatment effect in Lennox–Gastaut syndrome: Analysis from two randomized controlled trials 由 Michael Privitera, Hari Bhathal, Matthew H. Wong, J. Helen Cross, Elaine Wirrell, Eric D. Marsh, Maria Mazurkiewicz‐Bełdzińska, Vicente Villanueva, Daniel Checketts, Volker Knappertz, Kevan VanLandingham

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Add‐on cannabidiol in patients with Dravet syndrome: Results of a long‐term open‐label extension trial

    Add‐on cannabidiol in patients with Dravet syndrome: Results of a long‐term open‐label extension trial 由 Ingrid E. Scheffer, Jonathan J. Halford, Ian Miller, Rima Nabbout, Rocío Sánchez‐Carpintero, Yael Shiloh‐Malawsky, Matthew H. Wong, Marta Żołnowska, Daniel Checketts, Eduardo Dunayevich, Orrin Devinsky

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results

    Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results 由 Linda Laux, E. Martina Bebin, Daniel Checketts, Michael Chez, Robert Flamini, Eric D. Marsh, Ian Miller, Kathryn Nichol, Yong Park, Eric Segal, Laurie E. Seltzer, Jerzy P. Szaflarski, Elizabeth A. Thiele, Arie Weinstock

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Long‐term safety and efficacy of add‐on cannabidiol in patients with Lennox–Gastaut syndrome: Results of a long‐term open‐label extension trial

    Long‐term safety and efficacy of add‐on cannabidiol in patients with Lennox–Gastaut syndrome: Results of a long‐term open‐label extension trial 由 Anup D. Patel, Maria Mazurkiewicz‐Bełdzińska, Richard Chin, António Gil‐Nagel, Boudewijn Gunning, Jonathan J. Halford, Wendy G. Mitchell, Μ. Scott Perry, Elizabeth A. Thiele, Arie Weinstock, Eduardo Dunayevich, Daniel Checketts, Orrin Devinsky

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results

    Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results 由 Jerzy P. Szaflarski, E. Martina Bebin, Anne M. Comi, Anup D. Patel, Charuta Joshi, Daniel Checketts, Jules C. Beal, Linda Laux, Lisa M. De Boer, Matthew H. Wong, Merrick Lopez, Orrin Devinsky, Paul D. Lyons, Pilar Pichon Zentil, Robert Wechsler

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex

    Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex 由 Elizabeth A. Thiele, E. Martina Bebin, Hari Bhathal, Floor E. Jansen, Katarzyna Kotulska, John A. Lawson, Finbar O’Callaghan, Michael L. Wong, Farhad Sahebkar, Daniel Checketts, Volker Knappertz, John S. Archer, Daniel H. Arndt, Todd F. Barron, E. Martina Bebin, Hari Bhathal, Verónica Cantarín Extremera, Rocío Sánchez‐Carpintero, Michael A. Ciliberto, Hannah R. Cock, Marie‐Claire Y. de Wit, Orrin Devinsky, Mercé Falip, Francis Filloux, Nathan B. Fountain, Jacek Gawłowicz, Robert Greenwood, Khalid Hamandi, Floor E. Jansen, Charuta Joshi, Sergiusz Jóźwiak, Pavel Klein, Katarzyna Kotulska, Patrick Kwan, John A. Lawson, Paweł Lisewski, Ian Miller, Richard P. Morse, Ali S. Mostajelean, Danielle Nolan, Terence J. O’Brien, Finbar O’Callaghan, Fernando Paredes-Carmona, Μ. Scott Perry, Federico Ramos, David C. Reutens, Colin Roberts, Russell P. Saneto, Gregory B. Sharp, Anurag Saxena, Steven Sparagana, Priyamvada Tatachar, Elizabeth A. Thiele, James W. Wheless, Elaine Wirrell, Matthew H. Wong, Michael Wong, Joyce Y. Wu, Marta Żołnowska

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: